Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2025 February;116(1) > Minerva Medica 2025 February;116(1):13-21

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Medica 2025 February;116(1):13-21

DOI: 10.23736/S0026-4806.21.07145-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Delayed treatment with endostatin displays a protective role against pulmonary hypertension by targeting VEGF pathway

Shuai HUANG 1, Nannan LI 2, Dong YAN 3 ✉

 

ACCESS OPTIONS

Purchase access

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Personal subscriptions

Access as an individual subscriber


Institutional access

Access through your institution

Subscribe to this journal

Subscribe to Minerva Medica


Recommend to your librarian

top of page

 

Copyright © 2025 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions